Dedicare AB (publ)

LSE:0P3K Stock Report

Market Cap: SEK 538.4m

Dedicare Past Earnings Performance

Past criteria checks 3/6

Dedicare has been growing earnings at an average annual rate of 25.9%, while the Healthcare industry saw earnings growing at 31.3% annually. Revenues have been growing at an average rate of 21.4% per year. Dedicare's return on equity is 23.6%, and it has net margins of 3.7%.

Key information

25.9%

Earnings growth rate

25.2%

EPS growth rate

Healthcare Industry Growth12.6%
Revenue growth rate21.4%
Return on equity23.6%
Net Margin3.7%
Next Earnings Update07 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Dedicare makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

LSE:0P3K Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,798662000
30 Jun 241,861891910
31 Mar 241,900962000
31 Dec 231,9731102000
30 Sep 232,011102560
30 Jun 231,9371022040
31 Mar 231,8821051400
31 Dec 221,7721011800
30 Sep 221,62393550
30 Jun 221,50484360
31 Mar 221,37976180
31 Dec 211,2506600
30 Sep 211,143611390
30 Jun 211,063551140
31 Mar 2198042920
31 Dec 2088536700
30 Sep 2082329620
30 Jun 2078323620
31 Mar 2076226620
31 Dec 1977626620
30 Sep 1978428650
30 Jun 1979431650
31 Mar 1980332650
31 Dec 1881238650
30 Sep 1881242610
30 Jun 1878743610
31 Mar 1877850610
31 Dec 1778560610
30 Sep 1778168530
30 Jun 1775972530
31 Mar 1771665530
31 Dec 1665053530
30 Sep 16603421490
30 Jun 16585331490
31 Mar 16573301490
31 Dec 15573301490
30 Sep 155673100
30 Jun 155483100
31 Mar 155232800
31 Dec 144982300
30 Sep 144821700
30 Jun 144681400
31 Mar 144671300
31 Dec 134691400

Quality Earnings: 0P3K has high quality earnings.

Growing Profit Margin: 0P3K's current net profit margins (3.7%) are lower than last year (5.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 0P3K's earnings have grown significantly by 25.9% per year over the past 5 years.

Accelerating Growth: 0P3K's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 0P3K had negative earnings growth (-34.8%) over the past year, making it difficult to compare to the Healthcare industry average (15.5%).

Return on Equity

High ROE: 0P3K's Return on Equity (23.6%) is considered high.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 16:49
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dedicare AB (publ) is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stefan KnutssonABG Sundal Collier Sponsored
Rebecka GärderupABG Sundal Collier Sponsored
Stefan Erik AnderssonSEB